Maes, K., De Smedt, E., Kassambara, A., Hose, D., Seckinger, A., Van Valckenborgh, E., . . . De Bruyne, E. (2014). In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma. Oncotarget.
استشهاد بنمط شيكاغوMaes, Ken, et al. "In Vivo Treatment With Epigenetic Modulating Agents Induces Transcriptional Alterations Associated With Prognosis and Immunomodulation in Multiple Myeloma." Oncotarget 2014.
MLA استشهادMaes, Ken, et al. "In Vivo Treatment With Epigenetic Modulating Agents Induces Transcriptional Alterations Associated With Prognosis and Immunomodulation in Multiple Myeloma." Oncotarget 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.